Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer. - WLNS TV 6 Lansing - Jackson | Your Local News Leader

Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: CureXchange

The American Cancer Society puts 16% of contributions into cancer research, according to its Annual Report. CureLauncher is the new way to put 91% of contributions directly into new cancer treatments. Each person can now make a real difference.

Bloomfield Hills, MI (PRWEB) December 05, 2012

Vernon Hill is a prostate cancer survivor who led the Relay for Life for three years. He helped raise $900,000, but then suddenly quit. In a story on WNCT News 9, Hill said he believed most of the money went to cancer research. He found out the American Cancer Society puts only 16% of its nearly 1 billion dollar income to what he thinks is most important, cancer research.

According to the American Cancer Society’s Annual Report, 16% of its income goes to “support provided to academic institutions and scientists to seek new knowledge about the causes, prevention and cure of cancer”. Is that a high enough percent to cure cancer?

CureLauncher puts as much money as possible directly into new cancer treatments. “Each person can see exactly where their contribution is used and how it makes a difference”, said President, Stephen Goldner, JD, RAC. "CureLauncher.com lets you see a new breast cancer treatment in development and connect with the dedicated scientists who are saving lives".    

Dr. Lee Roy Morgan is an esteemed cancer research and has been awarded funding by the National Institutes of Health (NIH) for his work. However, government funding cuts to the NIH may prevent Dr. Morgan from advancing his new breast cancer treatment; abbreviated name DM-CHOC-PEN. Contributions on cureLauncher.com will allow Dr. Morgan to continue developing this cure.

“We are working through the FDA to move this program forward as quickly as possible” said Dr. Morgan. Ninety one percent of all money donated on cureLauncher will be used to make drug supplies for the next clinical trial. “These donations will make a huge difference toward our goal of improving cancer patients’ lives”.

Each person who donates $25 or more to Dr. Morgan’s research can write a personal and confidential email and receive Dr. Morgan's reply.

The timing for cureLauncher’s introduction is critical. The fiscal cliff is calling for funding to the NIH to be cut by $2.5 billion and eliminate 300 research grants through the National Cancer Institute, said the Biotechnology Industry Organization.

“Anyone who’s been affected by cancer knows how important it is to find new ways of fighting it”, said cureLauncher Vice President, David Fuehrer. “I am a two-time cancer survivor and alive today because of advances in the way cancer is treated. Now with cureLauncher, even small donations make a big impact”.    

Get involved. Find. Fund. Cure.

About CureLauncher
CureLauncher is an online community dedicated to funding new cancer treatments. It connects patients to lifesaving medical research and generates support for new cancer treatments in a way never before possible. Advocates of the research interact with each other and leading medical professionals to generate support.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebcureLauncher/New_Cancer_Treatment/prweb10205696.htm